Pharming Healthcare, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$8.5M
Doctors Paid
5,565
Transactions
25,259
2024 Total
$1.9M
Payment Breakdown by Category
Consulting$2.3M (26.6%)
Research$2.1M (25.1%)
Food & Beverage$654,164 (7.7%)
Travel$559,066 (6.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $2.7M | 1,124 | 31.9% |
| Consulting Fee | $2.3M | 777 | 26.6% |
| Unspecified | $2.1M | 83 | 25.1% |
| Food and Beverage | $654,164 | 20,550 | 7.7% |
| Travel and Lodging | $559,066 | 2,301 | 6.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $172,349 | 94 | 2.0% |
| Education | $9,119 | 330 | 0.1% |
Payments by Type
General
$6.4M
25,176 transactions
Research
$2.1M
83 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| COVID 19 US Study | $652,517 | 0 | 24 |
| LE 3301 | $280,418 | 2 | 9 |
| LE 3302 | $241,114 | 4 | 25 |
| Single-site, Open-Label, Pilot Study to Evaluate the Benefit of RUCONEST in Subjects with CVID Who Experience ADRs Related to IVIG Infusions | $167,173 | 0 | 1 |
| CVID-Ruconest A single site open label, study to evaluate the benefits of Ruconest in subjects with CVID who experience ADRs related to IVG infusion | $135,350 | 0 | 2 |
| Treatment of hereditary angioedema prodrom with recombinant human C-1 esterase inhibitor Ruconest | $134,167 | 0 | 2 |
| A Phase III,Single Center,Randomized,Double-Blind,Placebo-Controlled Study to Evaluate the Feasibility of Using Human Recombinant C1 InhibitorRUCONEST as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function in Recipients of Kidneys From Donation After Cardio-Circulatory Death | $117,443 | 0 | 3 |
| Treatment Of Hereditary Angioedema Prodrome With Recombinant Human C1-Esterase Inhibitor Ruconest | $112,874 | 0 | 3 |
| Ruconest in DCDD Kidney Transplantation Human recombinant C1 inhibitor as a therapeutic strategy to reduce the incidence of delayed graft function in recipients of kidney from donation after cardio-circulatory death | $103,699 | 0 | 2 |
| A Randomized, Double Blind, Placebo Controlled, Cross-Over, Proof-of-Concept Study to Evaluate the Benefit of RU CO NEST (Cl Esterase Inhibitor [recombinant]) in Improving Neurological Symptoms in Post-SARS-CoV-2 Infection | $85,000 | 0 | 1 |
| VID-Ruconest A single site open label, study to evaluate the benefits of Ruconest in subjects with CVID who experience ADRs related to IVG infusion | $60,875 | 0 | 1 |
| C1 1209 study open label, phase II, single arm study to evaluate the safety, immunogenicity, pharmacokinetics and efficacy of recombinant human C1 inhibitor for treatment of acute attacks in pediatric patients with HAE from 2 up to and including 13 years of age | $28,500 | 0 | 1 |
| Trio Health APDS Registry | $11,038 | 5 | 6 |
| Consulted with European CoWorkers | $2,220 | 1 | 2 |
| CDZ173X2201E1 | $100.00 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Raffi Tachdjian, M.d, M.D | Pediatric Allergy/Immunology | Santa Monica, CA | $454,845 | $0 |
| Marc Riedl, Md, MD | Allergy & Immunology | San Diego, CA | $282,992 | $0 |
| Douglas Jones, M.d, M.D | Internal Medicine | Layton, UT | $237,405 | $0 |
| Dr. Jay Kashkin, Md, MD | Allergy | Fair Lawn, NJ | $218,619 | $0 |
| Maeve O'connor, Md, MD | Allergy & Immunology | Charlotte, NC | $215,898 | $0 |
| Dr. Huamin Li, Md, Phd, MD, PHD | Allergy | Wheaton, MD | $207,939 | $0 |
| John Anderson, M.d, M.D | Student in an Organized Health Care Education/Training Program | Homewood, AL | $146,178 | $0 |
| Michael Manning, Md, MD | Allergy & Immunology | Scottsdale, AZ | $144,573 | $0 |
| Dr. Nicholas Hartog, M.d, M.D | Allergy & Immunology | Grand Rapids, MI | $139,828 | $0 |
| Dareen Siri, M.d, M.D | Allergy & Immunology | Normal, IL | $130,805 | $0 |
| Shahnaz Fatteh, Md, MD | Allergy & Immunology | Plantation, FL | $123,145 | $0 |
| Dr. Jack Eades, Md, MD | Allergy & Immunology | Macon, GA | $110,497 | $0 |
| Jonathan Bernstein, Md, MD | Internal Medicine | Cincinnati, OH | $105,543 | $0 |
| Dr. Mark Davis-Lorton, M.d, M.D | Allergy & Immunology | Tarrytown, NY | $98,501 | $0 |
| Dr. Eveline Wu, Md, MD | Pediatric Rheumatology | Chapel Hill, NC | $97,870 | $0 |
| Jolan Walter, M.d, M.D | Allergy & Immunology | St Petersburg, FL | $96,434 | $0 |
| Russell Settipane, Md, MD | Allergy & Immunology | Middletown, RI | $96,293 | $0 |
| Dr. William Lumry, M.d, M.D | Specialist | Dallas, TX | $94,090 | $0 |
| Dr. Rafael Zaragoza Urdaz, M.d., Ph.d, M.D., PH.D | Allergy | San Juan, PR | $90,643 | $0 |
| Thomas Westbrook, M.d, M.D | Allergy & Immunology | Pensacola, FL | $89,661 | $0 |
| Daniel Soteres, Md, MD | Allergy | Colorado Springs, CO | $82,548 | $0 |
| Autumn Burnette, Md, MD | Allergy & Immunology | Washington, DC | $79,015 | $0 |
| Dr. Amit Mehta, M.d, M.D | Hematology & Oncology | Cary, NC | $78,285 | $0 |
| Mr. Nicholas Rider, D.o, D.O | Allergy & Immunology | Roanoke, VA | $75,331 | $0 |
| Douglas Johnston, Do, DO | Allergy & Immunology | Greenville, SC | $71,260 | $0 |
Ad
Top Products
- RUCONEST $6.1M
- JOENJA $1.3M
Associated Products (3)
- RUCONEST $6.1M
- JOENJA $1.3M
- RUCONEST C1 ESTERASE INHIBITOR RECOMBINANT $112,704
Payment Categories
- Food & Beverage $654,164
- Consulting $2.3M
- Travel & Lodging $559,066
- Research $2.1M
About Pharming Healthcare, Inc.
Pharming Healthcare, Inc. has made $8.5M in payments to 5,565 healthcare providers, recorded across 25,259 transactions in the CMS Open Payments database. In 2024, the company paid $1.9M. The top product by payment volume is RUCONEST ($6.1M).
Payments were distributed across 128 medical specialties. The top specialty by payment amount is Allergy & Immunology ($3.2M to 1,283 doctors).
Payment categories include: Food & Beverage ($654,164), Consulting ($2.3M), Research ($2.1M), Travel & Lodging ($559,066).
Pharming Healthcare, Inc. is associated with 3 products in the CMS Open Payments database.